Achyut Healthcare Limited (ACHYUT.BO)
INR 4.41
(0.0%)
INR 4.41
(0.0%)
| Year | Inventory | Inventory Growth |
|---|---|---|
| 2023 | 568 Thousand INR | -87.47% |
| 2022 | 4.53 Million INR | 251.86% |
| 2021 | 1.28 Million INR | 34.31% |
| 2020 | 959 Thousand INR | 95899900.0% |
| 2019 | 1.00 INR | 0.0% |
| 2018 | - INR | 0.0% |
| Year | Inventory | Inventory Growth |
|---|---|---|
| 2024 Q2 | 578 Thousand INR | 0.0% |
| 2023 Q1 | 1.23 Million INR | -72.79% |
| 2023 FY | 1.52 Million INR | -66.28% |
| 2023 Q3 | 568 Thousand INR | -53.93% |
| 2023 Q4 | 568 Thousand INR | 0.0% |
| 2023 Q2 | 1.23 Million INR | 0.0% |
| 2022 Q1 | 568 Thousand INR | -56.35% |
| 2022 FY | 4.53 Million INR | 251.86% |
| 2022 Q4 | 4.53 Million INR | 43.01% |
| 2022 Q3 | 3.16 Million INR | 457.92% |
| 2022 Q2 | 568 Thousand INR | 0.0% |
| 2021 Q1 | 629 Thousand INR | 0.0% |
| 2021 FY | 1.28 Million INR | 34.31% |
| 2021 Q4 | 1.3 Million INR | 2.53% |
| 2021 Q3 | 1.26 Million INR | 101.75% |
| 2021 Q2 | 629 Thousand INR | 0.0% |
| 2020 FY | 959 Thousand INR | 95899900.0% |
| 2019 FY | 1.00 INR | 0.0% |
| 2018 FY | - INR | 0.0% |
| Name | Inventory | Inventory Difference |
|---|---|---|
| Ajanta Pharma Limited | 8.28 Billion INR | 99.993% |
| Amrutanjan Health Care Limited | 289.04 Million INR | 99.803% |
| Sigachi Industries Limited | 707.2 Million INR | 99.92% |
| Bal Pharma Limited | 878.11 Million INR | 99.935% |
| Ind-Swift Laboratories Limited | 104.57 Million INR | 99.457% |
| Medico Remedies Limited | 163.37 Million INR | 99.652% |
| Lasa Supergenerics Limited | 190.43 Million INR | 99.702% |
| Venus Remedies Limited | 1.21 Billion INR | 99.953% |
| Sun Pharma Advanced Research Company Limited | - INR | -Infinity% |
| Alpa Laboratories Limited | 136.65 Million INR | 99.584% |
| Nectar Lifesciences Limited | 7.09 Billion INR | 99.992% |
| Shilpa Medicare Limited | 3.44 Billion INR | 99.984% |
| Aarti Drugs Limited | 4.85 Billion INR | 99.988% |
| Lupin Limited | 49.53 Billion INR | 99.999% |
| Aurobindo Pharma Limited | 98.08 Billion INR | 99.999% |
| Zydus Lifesciences Limited | 34.41 Billion INR | 99.998% |
| Windlas Biotech Limited | 621.89 Million INR | 99.909% |
| Suven Life Sciences Limited | 7.08 Million INR | 91.983% |
| Eris Lifesciences Limited | 1.89 Billion INR | 99.97% |
| Valiant Laboratories Limited | 100.15 Million INR | 99.433% |
| J. B. Chemicals & Pharmaceuticals Limited | 5.02 Billion INR | 99.989% |
| Solara Active Pharma Sciences Limited | 3.59 Billion INR | 99.984% |
| Ipca Laboratories Limited | 24.71 Billion INR | 99.998% |
| Bliss GVS Pharma Limited | 1.18 Billion INR | 99.952% |
| Sun Pharmaceutical Industries Limited | 98.68 Billion INR | 99.999% |
| Bajaj HealthCare Limited | 1.44 Billion INR | 99.961% |
| RPG Life Sciences Limited | 1.01 Billion INR | 99.944% |
| Mankind Pharma Limited | 15.53 Billion INR | 99.996% |
| Laurus Labs Limited | 18.45 Billion INR | 99.997% |
| Piramal Pharma Limited | 21.75 Billion INR | 99.997% |
| Syncom Formulations (India) Limited | 210.81 Million INR | 99.731% |
| Torrent Pharmaceuticals Limited | 22.79 Billion INR | 99.998% |
| Alembic Pharmaceuticals Limited | 16.43 Billion INR | 99.997% |
| Glenmark Pharmaceuticals Limited | 25.13 Billion INR | 99.998% |
| Unichem Laboratories Limited | 7.04 Billion INR | 99.992% |
| Sequent Scientific Limited | 3.46 Billion INR | 99.984% |
| Novartis India Limited | 448.6 Million INR | 99.873% |
| Wanbury Limited | 360.23 Million INR | 99.842% |
| Suven Pharmaceuticals Limited | 2.31 Billion INR | 99.975% |
| Wockhardt Limited | 6.4 Billion INR | 99.991% |
| Themis Medicare Limited | 705.74 Million INR | 99.92% |
| Jagsonpal Pharmaceuticals Limited | 149.97 Million INR | 99.621% |
| Jubilant Pharmova Limited | 12.89 Billion INR | 99.996% |
| Glenmark Life Sciences Limited | 6.66 Billion INR | 99.991% |
| Dr. Reddy's Laboratories Limited | 63.55 Billion INR | 99.999% |
| Divi's Laboratories Limited | 31.84 Billion INR | 99.998% |
| NATCO Pharma Limited | 7 Billion INR | 99.992% |
| Gufic Biosciences Limited | 2 Billion INR | 99.972% |
| IOL Chemicals and Pharmaceuticals Limited | 4.24 Billion INR | 99.987% |
| Ind-Swift Limited | 640.91 Million INR | 99.911% |
| Procter & Gamble Health Limited | 1.09 Billion INR | 99.948% |
| FDC Limited | 3.88 Billion INR | 99.985% |
| Krebs Biochemicals & Industries Limited | 97.96 Million INR | 99.42% |
| Granules India Limited | 13 Billion INR | 99.996% |
| Medicamen Biotech Limited | 593.75 Million INR | 99.904% |
| Alkem Laboratories Limited | 26.61 Billion INR | 99.998% |
| AstraZeneca Pharma India Limited | 2.27 Billion INR | 99.975% |
| Biofil Chemicals and Pharmaceuticals Limited | 25.49 Million INR | 97.772% |
| Brooks Laboratories Limited | 96.1 Million INR | 99.409% |
| Megasoft Limited | - INR | -Infinity% |
| ZIM Laboratories Limited | 812.62 Million INR | 99.93% |
| Strides Pharma Science Limited | 11.26 Billion INR | 99.995% |
| Neuland Laboratories Limited | 3.5 Billion INR | 99.984% |
| Morepen Laboratories Limited | 2.48 Billion INR | 99.977% |
| Hikal Limited | 3.03 Billion INR | 99.981% |
| Indoco Remedies Limited | 3.53 Billion INR | 99.984% |
| Aarti Pharmalabs Limited | 6.42 Billion INR | 99.991% |
| Kilitch Drugs (India) Limited | 39.88 Million INR | 98.576% |
| Mangalam Drugs & Organics Limited | 1.23 Billion INR | 99.954% |
| Hester Biosciences Limited | 755.81 Million INR | 99.925% |